Yarlagadda S. Babu

2009

In 2009, Yarlagadda S. Babu earned a total compensation of $734.3K as Vice President, Drug Discovery at BioCryst Pharmaceuticals, a 41% increase compared to previous year.

Compensation breakdown

Bonus$242,736
Non-Equity Incentive Plan$75,734
Option Awards$90,000
Salary$313,537
Other$12,250
Total$734,257

Babu received $313.5K in salary, accounting for 43% of the total pay in 2009.

Babu also received $242.7K in bonus, $75.7K in non-equity incentive plan, $90K in option awards and $12.3K in other compensation.

Rankings

In 2009, Yarlagadda S. Babu's compensation ranked 5,494th out of 9,885 executives tracked by ExecPay. In other words, Babu earned more than 44.4% of executives.

ClassificationRankingPercentile
All
5,494
out of 9,885
44th
Division
Manufacturing
1,971
out of 3,690
47th
Major group
Chemicals And Allied Products
408
out of 866
53rd
Industry group
Drugs
261
out of 638
59th
Industry
Biological Products, Except Diagnostic Substances
45
out of 133
66th
Source: SEC filing on April 9, 2012.

Babu's colleagues

We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2009.

2009

Stuart Grant

BioCryst Pharmaceuticals

Chief Financial Officer

2009

Jon Stonehouse

BioCryst Pharmaceuticals

Chief Executive Officer

2009

David McCullough

BioCryst Pharmaceuticals

Vice President, Strategic Planning, Commercialization and Corporate Development

2009

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

News

You may also like